Last month, APCO Worldwide released findings of its fourth State of the U.S. Biopharmaceutical Industry report. The study, conducted by APCO’s research consultancy, APCO Insight, uses a “Return on Reputation” metric to assess an industry’s reputation, taking into account 54 attributes considered important by stakeholders, including sustainable innovation and pharmacovigilance. The ROR Indicator model was designd to help the industry and its companies see, quantitatively, how a change in reputat...